Rep. Mike Rogers applauds anthrax vaccine contract

Michigan Representative Mike Rogers announced on Monday that an anthrax vaccine contract worth $1.2 billion over five years to deliver almost 45 million doses of anthrax vaccine is positive news for jobs in Lansing, Mich.
The Centers for Disease Control and Prevention announced on Monday that it had awarded the contract to Emergent BioSolutions, Inc., to deliver the vaccine doses to the Strategic National Stockpile.
“Today’s announcement is great news for jobs in Lansing," Rogers said. "Emergent’s scientists, researchers and engineers in Lansing are essential partners with the federal government in keeping America prepared and protected. Ten years ago our country was attacked with anthrax, and we know it is still the largest bioterror threat facing the United States.  Emergent's 400 employees in Lansing continue to manufacture the only federally approved vaccine for treating anthrax poisoning, and this contract will strengthen our national vaccine stockpile for years to come.”
Rogers authored the Pandemic and All-Hazard Preparedness Reauthorization Act of 2011 (H.R. 2405) in an effort to strengthen and expand federal bioterrorism preparedness programs. The bipartisan legislation passed the House Energy and Commerce Committee by a unanimous voice vote on July 28.
The first deliveries of the award are expected to commence with 8.5 million doses delivered during 2011.